Sharescart Research Club logo

Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹977 Cr.
Stock P/E
193.8
P/B
2.2
Current Price
₹180
Book Value
₹ 80.5
Face Value
10
52W High
₹416
52W Low
₹ 125
Dividend Yield
0%

Quick Heal Tech Overview

Business

Quick Heal Technologies Ltd. is an Indian cybersecurity solutions company. Its core business involves developing and selling security software and services for consumers, small and medium enterprises (SMEs), government organizations, and large enterprises. The company offers a wide range of products including antivirus, internet security, total security, mobile security, and enterprise-grade solutions like endpoint security, network security, data protection, and unified threat management (UTM). It primarily makes money through software license sales, annual renewals for its products, and providing cybersecurity services.

Revenue Mix

Quick Heal operates primarily through two segments:

Retail/Consumer (Quick Heal brand): Focuses on individual users and home offices, offering products like Quick Heal AntiVirus Pro, Internet Security, and Total Security. This segment has historically been the dominant revenue contributor, leveraging a strong brand recall and extensive distribution network across India.

Enterprise (Seqrite brand): Caters to businesses, government entities, and large enterprises, offering advanced cybersecurity solutions such as Endpoint Detection and Response (EDR), Extended Detection and Response (XDR), firewall, server security, data loss prevention, and mobile device management. This segment is a key growth area for the company.

Specific revenue contribution percentages fluctuate, but the company is actively pushing to increase the share of its enterprise segment.

Industry

The cybersecurity industry is a rapidly growing but highly competitive global market. It is characterized by evolving threat landscapes, continuous innovation, and the presence of numerous global and local players. Quick Heal Technologies is positioned as a leading indigenous cybersecurity company in India. It holds a strong market share in the Indian retail antivirus segment due to its established brand and distribution. In the enterprise segment, it competes with global giants like Palo Alto Networks, Fortinet, CrowdStrike, and Kaspersky, as well as other local providers. Quick Heal differentiates itself through its understanding of the Indian threat landscape, extensive local support, and a comprehensive product portfolio tailored for various segments within India.

MOAT

Brand Recognition: "Quick Heal" is a well-established and recognized brand in the Indian consumer cybersecurity market, fostering trust and preference among users.

Extensive Distribution Network: The company boasts a vast offline distribution network across India, particularly valuable for reaching consumers and smaller businesses in tier-2 and tier-3 cities.

Localized R&D & Threat Intelligence: Quick Heal has in-house R&D capabilities and a focus on threat intelligence specific to the Indian subcontinent, allowing it to address local cyber threats effectively.

Customer Support: Strong local language customer support and service infrastructure contribute to customer loyalty.

Switching Costs: For enterprise clients, migrating from one security solution to another can involve significant integration efforts, training, and operational disruptions, creating a degree of stickiness for existing clients.

Growth Drivers

Increasing Digital Adoption in India: Rapid growth in internet users, smartphones, e-commerce, and digital payments fuels the demand for cybersecurity across consumer and enterprise segments.

Rising Cyber Threats: The increasing sophistication and volume of cyberattacks globally and within India necessitate robust security solutions.

Government Initiatives: "Digital India" and "Make in India" initiatives, along with stricter data protection regulations (e.g., DPDP Act), drive demand for indigenous and compliant cybersecurity solutions from government and public sector undertakings.

Growth in Enterprise Segment (Seqrite): Significant untapped potential in the Indian SME market, large enterprises, and government sector for advanced security solutions.

Cloud Adoption: The shift of businesses to cloud infrastructure creates new demand for cloud security, a growing area for Quick Heal.

New Product Development: Continuous innovation and expansion into advanced security domains like EDR, XDR, IoT security, and threat intelligence.

Risks

Intense Competition: The cybersecurity market is highly competitive, with established global players having deeper R&D budgets and wider market reach.

Rapid Technological Obsolescence: The cyber threat landscape evolves quickly, requiring continuous and significant R&D investment to keep products effective and relevant. Failure to innovate can lead to loss of market share.

Reliance on Indian Market: While a strength, a significant portion of revenue is concentrated in India, making the company susceptible to economic downturns or regulatory changes specific to the country.

Talent Retention: High demand for skilled cybersecurity professionals globally can lead to challenges in attracting and retaining top talent.

Piracy: Software piracy, particularly in the consumer segment, can impact sales and revenue.

Product Efficacy: Any major security breach that bypasses Quick Heal's protection could severely damage its reputation and client trust.

Management & Ownership

Quick Heal Technologies is a promoter-led company. It was co-founded by Kailash Katkar (Chairman & MD) and Sanjay Katkar (CTO & Jt. MD), who have been instrumental in its growth and strategic direction. The management team generally comprises experienced professionals in the cybersecurity domain. The promoters hold a significant stake in the company, aligning their interests with long-term growth. The remaining ownership is distributed among institutional investors, mutual funds, and public shareholders.

Outlook

Quick Heal Technologies is strategically positioned to capitalize on India's burgeoning digital economy and the escalating need for robust cybersecurity. The company's established brand in the retail segment and growing traction in the enterprise segment (Seqrite) provide a dual growth engine. Continued investment in R&D to counter evolving threats, along with an effective go-to-market strategy for its enterprise offerings, will be crucial. However, the company operates in an intensely competitive global market that demands constant innovation and significant capital expenditure. Its ability to effectively scale its enterprise solutions, potentially expand into new geographies, and fend off global competitors will determine its long-term success amidst the dynamic cybersecurity landscape.

Quick Heal Tech Share Price

Live · BSE / NSE · Inception: 1995
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Quick Heal Tech Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 82 80 70 73 71 65 57 84 72 49
Other Income 4 7 5 5 5 6 6 4 9 4
Total Income 86 87 75 79 76 71 63 88 80 52
Total Expenditure 70 70 68 70 74 74 67 74 71 78
Operating Profit 16 17 8 8 1 -3 -4 14 9 -26
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 3 3 3 3 3 4 3 3 4 4
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 13 14 5 5 -2 -7 -7 10 6 -30
Provision for Tax 2 -0 1 1 -2 -3 -1 2 -1 -10
Profit After Tax 10 14 4 4 0 -3 -6 8 7 -20
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 10 14 4 4 0 -3 -6 8 7 -20
Adjusted Earnings Per Share 1.9 2.6 0.8 0.8 0 -0.6 -1 1.5 1.2 -3.7

Quick Heal Tech Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 286 302 300 318 315 286 333 342 278 292 280 262
Other Income 8 10 28 30 33 32 28 19 22 21 21 23
Total Income 294 312 328 348 348 318 361 361 300 313 300 283
Total Expenditure 194 200 210 198 187 195 195 235 276 274 286 290
Operating Profit 100 112 119 150 161 123 166 126 24 39 14 -7
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 20 24 31 27 24 22 19 17 16 13 13 14
Exceptional Income / Expenses 0 0 -4 0 0 0 0 0 0 0 0 0
Profit Before Tax 80 88 84 123 137 101 146 109 8 26 1 -21
Provision for Tax 26 30 31 40 45 27 39 25 2 2 -4 -10
Profit After Tax 54 58 53 83 92 74 107 83 6 24 5 -11
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 54 58 53 83 92 74 107 83 6 24 5 -11
Adjusted Earnings Per Share 0 8.3 7.6 11.8 13 11.6 16.7 14.3 1.2 4.5 0.9 -2

Quick Heal Tech Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 331 629 662 724 790 644 751 628 420 437 441
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities -5 -6 -6 -2 -5 -0 1 2 2 -1 -3
Total Current Liabilities 97 86 70 55 59 50 74 86 72 73 79
Total Liabilities 423 710 725 776 844 694 827 716 493 509 517
Fixed Assets 111 142 185 173 165 158 146 112 100 85 84
Other Non-Current Assets 92 77 45 35 46 57 49 70 70 60 62
Total Current Assets 221 491 495 568 634 479 631 535 323 364 371
Total Assets 423 710 725 776 844 694 827 716 493 509 517

Quick Heal Tech Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 5 13 117 59 12 13 10 16 8 12 38
Cash Flow from Operating Activities 77 78 36 94 61 71 99 80 31 18 -22
Cash Flow from Investing Activities -53 -163 -73 -122 -37 148 -92 126 185 6 16
Cash Flow from Financing Activities -17 189 -20 -19 -24 -221 0 -214 -212 2 -10
Net Cash Inflow / Outflow 7 104 -57 -47 1 -3 6 -9 4 26 -17
Closing Cash & Cash Equivalent 13 117 59 12 13 10 16 8 12 38 21

Quick Heal Tech Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0 8.27 7.59 11.79 13.01 11.59 16.66 14.34 1.21 4.53 0.93
CEPS(Rs) 12.12 11.66 12.01 15.62 16.35 14.97 19.69 17.34 4.22 6.88 3.33
DPS(Rs) 7.5 2.5 2.5 3 2 4 4 4.5 2.5 3 0
Book NAV/Share(Rs) 0 89.72 94.17 102.63 111.6 99.94 116.56 106.98 77.29 79.81 78.96
Core EBITDA Margin(%) 32.09 33.74 30.05 37.81 40.61 31.94 41.33 31.25 0.68 6.02 -2.36
EBIT Margin(%) 27.9 29.17 27.96 38.77 43.51 35.41 43.88 31.79 2.88 9.03 0.44
Pre Tax Margin(%) 27.9 29.17 27.96 38.77 43.51 35.41 43.88 31.79 2.88 8.98 0.36
PAT Margin (%) 18.81 19.17 17.74 26.08 29.16 26.01 32.12 24.33 2.3 8.31 1.8
Cash Profit Margin (%) 25.87 27.02 28.06 34.54 36.64 33.58 37.97 29.42 8.05 12.63 6.44
ROA(%) 13.47 10.23 7.42 11.06 11.33 9.68 14.07 10.79 1.06 4.84 0.98
ROE(%) 16.21 12.07 8.26 12.01 12.16 10.41 15.39 12.15 1.24 5.79 1.18
ROCE(%) 24.05 18.34 12.99 17.82 18.1 14.13 20.94 15.76 1.53 6.15 0.28
Receivable days 85.55 94.93 115.33 114.82 132.21 151.93 144.55 172.19 193.34 159.12 194.85
Inventory Days 8.97 8.77 8.89 7.78 6.38 7.42 5.25 4.34 6.1 4.57 3.28
Payable days 768.48 956.17 1165.35 1037.41 1026.39 1411.24 1392.01 1496.02 1923 2364.48 1914.84
PER(x) 0 26.29 31.15 22.52 17.34 7.01 11.2 12.38 110.45 103.91 307.24
Price/Book(x) 0 2.42 2.51 2.59 2.02 0.81 1.6 1.66 1.72 5.9 3.63
Dividend Yield(%) 0 1.15 1.06 1.13 0.89 4.92 2.14 2.53 1.88 0.64 0
EV/Net Sales(x) 0.17 4.15 4.83 5.36 4.63 1.54 3.34 2.83 2.5 8.5 5.46
EV/Core EBITDA(x) 0.48 11.21 12.22 11.35 9.08 3.59 6.73 7.67 28.95 63.71 107.72
Net Sales Growth(%) 17.82 5.58 -0.7 6.11 -1.06 -9.14 16.39 2.66 -18.66 4.91 -4.19
EBIT Growth(%) -7.21 10.37 -4.81 47.15 11.02 -26.06 44.24 -25.63 -92.62 228.43 -95.37
PAT Growth(%) -7.84 7.63 -8.08 55.95 10.62 -18.96 43.76 -22.23 -92.31 278.75 -79.21
EPS Growth(%) 0 0 -8.18 55.31 10.35 -10.94 43.74 -13.92 -91.59 275.62 -79.4
Debt/Equity(x) 0 0 0 0 0 0 0 0 0 0 0
Current Ratio(x) 2.28 5.7 7.11 10.37 10.69 9.56 8.53 6.2 4.5 4.96 4.72
Quick Ratio(x) 2.2 5.62 6.99 10.27 10.6 9.43 8.49 6.15 4.43 4.93 4.69
Interest Cover(x) 0 0 0 0 0 0 0 0 0 202.62 5.55
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0 0 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -4% -6% 0% 0%
Operating Profit CAGR -64% -52% -35% -18%
PAT CAGR -79% -61% -42% -21%
Share Price CAGR -51% +7% -5% -3%
ROE Average +1% +3% +7% +10%
ROCE Average 0% +3% +9% +14%

Quick Heal Tech Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 71.5 %
FII 0.73 %
DII (MF + Insurance) 1.16 %
Public (retail) 28.5 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 72.7672.4872.4472.0871.9271.8271.7971.6371.5471.5
FII 1.661.651.541.611.812.021.160.50.450.73
DII 1.442.062.412.622.842.632.582.332.291.16
Public 27.2427.5227.5627.9228.0828.1828.2128.3728.4628.5
Others 0000000000
Total 100100100100100100100100100100

Quick Heal Tech Peer Comparison

IT - Software Edit Columns

Quick Heal Tech Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Quick Heal Tech Pros & Cons

Pros

  • Debtor days have improved from 2364.48 to 1914.84days.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 3% over the last 3 years.
  • The company has delivered a poor profit growth of -41% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp